Thus, the potential of EA to halt Col1a1 and abnormal collagen production can explain its potential to restore hematopoiesis and ameliorate the cancer inhibition of common myeloid and megakaryocytic/erythroid progenitors as discussed above in cancer mice. The gene discussed is COL1A1; the disease is cancer.